Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pelin Aksungur, Murat Demirbilek, Emir B. Denkbaş & Nurşen Ünlü. (2012) Comparative evaluation of cyclosporine A/HPβCD-incorporated PLGA nanoparticles for development of effective ocular preparations. Journal of Microencapsulation 29:6, pages 605-613.
Read now
Read now
Anne J Lee & Ivan Goldberg. (2011) Emerging drugs for ocular hypertension. Expert Opinion on Emerging Drugs 16:1, pages 137-161.
Read now
Read now
Maryam Ali & Mark Edward Byrne. (2008) Challenges and solutions in topical ocular drug-delivery systems. Expert Review of Clinical Pharmacology 1:1, pages 145-161.
Read now
Read now
Deepta Ghate & Henry F Edelhauser. (2006) Ocular drug delivery. Expert Opinion on Drug Delivery 3:2, pages 275-287.
Read now
Read now
Articles from other publishers (22)
Triveni Shelke & Monalisa Mishra. 2023. Nanotechnology in Ophthalmology. Nanotechnology in Ophthalmology
321
334
.
Jingjing Yang, Yu Ma, Qing Luo, Zhen Liang, Ping Lu, Fei Song, Zhen Zhang, Tianyang Zhou & Junjie Zhang. (2022) Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application. European Journal of Pharmaceutical Sciences 168, pages 106078.
Crossref
Crossref
Carmen M. Arroyo-García, Daniela Quinteros, Santiago D. Palma, Cesáreo J. Jiménez de los Santos, José R. Moyano, Antonio M. Rabasco & María Luisa González-Rodríguez. (2021) Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels. Pharmaceutics 13:12, pages 2010.
Crossref
Crossref
Olivia L. Lanier, Miranda G. Manfre, Claire Bailey, Zhen Liu, Zachary Sparks, Sandesh Kulkarni & Anuj Chauhan. (2021) Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations. AAPS PharmSciTech 22:3.
Crossref
Crossref
E. Sánchez-López, Eliana B. Souto, M. Espina, A. Cano, M. Ettcheto, Antoni Camins & M. L. García. 2021. Ophthalmic Product Development. Ophthalmic Product Development
409
447
.
Blanca Lorenzo-Veiga, Patricia Diaz-Rodriguez, Carmen Alvarez-Lorenzo, Thorsteinn Loftsson & Hakon Hrafn Sigurdsson. (2020) In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation. Nanomaterials 10:4, pages 709.
Crossref
Crossref
Marcelo Luís Occhiutto, Raul C. Maranhão, Vital Paulino Costa & Anastasios G. Konstas. (2019) Nanotechnology for Medical and Surgical Glaucoma Therapy—A Review. Advances in Therapy 37:1, pages 155-199.
Crossref
Crossref
Pinal Chaudhari, Vivek M. Ghate & Shaila A. Lewis. (2019) Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics. Experimental Eye Research 189, pages 107829.
Crossref
Crossref
Moiseev, Morrison, Steele & Khutoryanskiy. (2019) Penetration Enhancers in Ocular Drug Delivery. Pharmaceutics 11:7, pages 321.
Crossref
Crossref
Phatsawee Jansook, Noriko Ogawa & Thorsteinn Loftsson. (2018) Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. International Journal of Pharmaceutics 535:1-2, pages 272-284.
Crossref
Crossref
Marwa Shukr. (2014) Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia. Archives of Pharmacal Research 37:7, pages 882-889.
Crossref
Crossref
Tiantian Ye, Kun Yuan, Wenji Zhang, Shuangshuang Song, Fen Chen, Xinggang Yang, Shujun Wang, Jianwei Bi & Weisan Pan. (2013) Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery. Asian Journal of Pharmaceutical Sciences 8:4, pages 207-217.
Crossref
Crossref
Phatsawee Jansook, Marcus E. Brewster & Thorsteinn Loftsson. 2011. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine
145
158
.
Nilüfer Tarimci. 2011. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine
131
144
.
Füsun Acartürk & Nevin Çelebi. 2011. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine
45
64
.
Shayne Cox GadIlva D. Rupenthal & Raid G. Alany. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Huei-Jen Kao, Yu-Li Lo, Hong-Ru Lin & Shi-Ping Yu. (2006) Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. Journal of Pharmacy and Pharmacology 58:2, pages 179-186.
Crossref
Crossref
G.M. El Maghraby & A.H. Alomrani. (2010) Effects of hydroxypropyl-β-cyclodextrin, gel and in situ gelling systems on the stability of hydrocortisone after gamma irradiation. Journal of Drug Delivery Science and Technology 20:5, pages 385-389.
Crossref
Crossref
Bizhan Malaekeh-Nikouei, Sayyed A. Sajadi Tabassi, Hossein Ashari & Ali Gholamzadeh. (2009) Evaluation the effect of cyclodextrin complexation on aqueous solubility of fluorometholone to achieve ophthalmic solution. Journal of Inclusion Phenomena and Macrocyclic Chemistry 65:3-4, pages 335-340.
Crossref
Crossref
Ripal Gaudana, J. Jwala, Sai H. S. Boddu & Ashim K. Mitra. (2008) Recent Perspectives in Ocular Drug Delivery. Pharmaceutical Research 26:5.
Crossref
Crossref
Deepta Ghate & Henry F. Edelhauser. (2008) Barriers to Glaucoma Drug Delivery. Journal of Glaucoma 17:2, pages 147-156.
Crossref
Crossref
Rajeswari Challa, Alka Ahuja, Javed Ali & R. K. Khar. (2005) Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 6:2, pages E329-E357.
Crossref
Crossref